Perceptions of challenges in clinical pediatric research: a survey of Italian pediatricians

Alberto Eugenio Tozzi1, Ileana Croci2, Claudio Pignata3

  • 1Predictive and Preventive Medicine Research Unit, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio, 4, 00165, Rome, Italy.

Insights

Italian pediatricians face significant barriers to research, including time constraints and funding issues. Addressing these obstacles is crucial for advancing pediatric care and improving child health outcomes.

Area of Science:

  • Pediatric Research
  • Clinical Practice
  • Evidence-Based Medicine

Background:

  • Clinical research is vital for advancing pediatric care.
  • Pediatricians encounter unique barriers to research participation.
  • Understanding these obstacles is key to strengthening pediatric research capacity in Italy.

Purpose of the Study:

  • To investigate Italian pediatricians' perceptions of barriers and facilitators to research.
  • To explore needs related to conducting research, applying evidence, and publishing.
  • To inform strategies for enhancing pediatric research in Italy.

Main Methods:

  • Cross-sectional online survey of Italian pediatricians (April-May 2025).
  • 18-item questionnaire assessing barriers, facilitators, and needs.
  • Descriptive analysis and multilevel logistic regression.

Main Results:

  • Key barriers include balancing clinical/research duties (79.3%), funding access (67.9%), Ethics Committee delays (80.8%), and data sharing challenges (55.9%).
  • Many pediatricians find current research evaluation systems inadequate, with 78.2% favoring metrics reflecting patient impact.
  • Obstacles to publishing include limited time (75%), data analysis complexity (58.7%), and costs (55%). High interest exists for evidence summaries and AI training.

Conclusions:

  • Italian pediatricians face significant structural, organizational, and methodological research barriers.
  • Despite challenges, pediatricians are motivated and require training, support, and improved evaluation systems.
  • Enhancing funding, institutional support, and administrative processes is essential for advancing pediatric research and child health.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...